CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis
Background: Disease activity in the first years after a diagnosis of relapsing-remitting multiple sclerosis (RRMS) is a negative prognostic factor for long-term disability. Markers of both clinical and radiological responses to disease-modifying therapies (DMTs) are advocated. Objective: The objecti...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
SAGE Publishing
2022-06-01
|
| Ráidu: | Therapeutic Advances in Neurological Disorders |
| Liŋkkat: | https://doi.org/10.1177/17562864221092124 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|